News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Meda AB (MEDA-A.ST) Acquires OTC Product in the U.S.



12/7/2012 11:01:27 AM

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: Meda (STO:MEDAA) has signed an agreement to acquire MidNite, an OTC sleep-aid product. MidNite is well established in the U.S. and holds a market leading position within a growing category. Annualized revenues for MidNite are approximately 100 MSEK. After the MidNite acquisition, Meda’s OTC business in the US will have pro forma revenues of close to 400 MSEK. The acquisition is expected to be accretive to EPS in 2013. Transaction terms were not disclosed.

Read at BioSpace.com


comments powered by Disqus
Meda AB
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES